Getting return of investment from your research and development
CROs form an integral part in the current pharmaceutical climate, as a significant portion of pharma/biotech R&D budget is spent on outsourcing services.
As the trend of overall cost of drug development rises - the relationship between pharma and the CRO has and needs to evolve. To gain the best value and results (bio)pharma needs to consider CROs as a partner and not just as a provider of services to stand-alone projects.
Vital components of this partnership include having a shared vision and open communication channels, with dedicated teams committed to planning and organisation. With this strategy in place, sponsors and CROs can agree to manage their budget and resources over a period of time and on a number of projects - which allows amongst other things, familiarity with a drug development process and ability to combine synergies of past and future projects.
The top 10 CROs control over 50% of clinical trial market, while more than 1000 CROs compete for the rest. CRO alliance as a new business model creates new opportunities, and can provide significant advantages over small/local and global CRO players.
This webinar will address major advantages and possible risks of CRO alliance as a service provider for pharma and biotech.
Additionally, conditions ensuring quality, optimal functioning and service delivery by CRO alliance will be discussed.
Are sponsors ready to accept the Alliance as a service provider? Register for this webinar to learn how a CRO alliance is a great strategic opportunity.
SanaClis will share examples of its experience in working within the exQuisite Alliance.
Presented by
Natalia Fetkovska,
Sr. Partner
Natalia Fetkovska, MD, PhD has more than 20 years experience in managing clinical trials in Central & Eastern Europe including management of supplies. She played a key role in establishing and expanding Quintiles operations in C&EE especially in Russia and Ukraine (1996-2005). Since 2006 Natalia purchased majority ownership rights in SanaClis and acts as Senior Partner. She is actively involved in strategic business planning, key customer contacts and successful company growth.